Ionova Life Science is based in Shenzhen, China. It has raised $226M in total funding. Backed by Lilly Asia Ventures, Shenzhen Capital Group, Dyee Capital.
Ionova Life Science funding overview
Ionova Life Science is based in Shenzhen, China. Ionova Life Science has raised $226M in total disclosed funding. That places its disclosed total in the $100M–$250M range. The round record for Ionova Life Science runs through 2021; nothing later has been disclosed. Investors on record include Lilly Asia Ventures, Shenzhen Capital Group, Dyee Capital, Tsing Capital, Qingsong Capital. 5 distinct backers are named across the disclosed rounds.
Ionova Life Science at a glance
Total raised
$226M
Latest round date
August 2021
Headquarters
Shenzhen, China
Notable investors
Lilly Asia Ventures, Shenzhen Capital Group, Dyee Capital, Tsing Capital, Qingsong Capital
Frequently asked about Ionova Life Science funding
How much has Ionova Life Science raised?
Ionova Life Science has raised $226M in total disclosed funding across the rounds on record.
Who has invested in Ionova Life Science?
Lilly Asia Ventures, Shenzhen Capital Group, Dyee Capital, Tsing Capital, Qingsong Capital are named among the investors backing Ionova Life Science.
What was the latest Ionova Life Science funding round?
No round stage has been disclosed for Ionova Life Science.
Where is Ionova Life Science based?
Ionova Life Science is based in Shenzhen, China.
When did Ionova Life Science last raise?
The last disclosed Ionova Life Science round closed in August 2021.
Ionova Life Science totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Shenzhen below to benchmark round size and investor mix.
